Louisiana 2024 Regular Session

Louisiana House Bill HB361

Introduced
2/29/24  
Introduced
2/29/24  
Refer
2/29/24  
Refer
2/29/24  
Refer
3/11/24  
Refer
3/11/24  
Report Pass
4/9/24  
Report Pass
4/9/24  
Engrossed
4/16/24  
Engrossed
4/16/24  
Refer
4/17/24  
Refer
4/17/24  
Report Pass
5/1/24  
Enrolled
5/15/24  
Chaptered
5/23/24  
Chaptered
5/23/24  
Passed
5/23/24  

Caption

Provides relative to colorectal cancer screening (EN NO IMPACT See Note)

Impact

The passage of HB 361 is expected to significantly impact state laws regarding health insurance requirements, specifically concerning preventive cancer screenings. By standardizing coverage for colorectal cancer screening, the bill encourages broader access to essential medical services, thereby promoting public health initiatives aimed at reducing cancer mortality rates. Additionally, it reinforces the importance of regular screenings among populations at risk, which is vital for early intervention and improved patient outcomes.

Summary

House Bill 361 focuses on enhancing healthcare access by mandating insurance coverage for routine colorectal cancer screening in Louisiana. The legislation aims to align with the latest recommendations from reputable medical organizations, including the American College of Gastroenterology and the American Cancer Society, ensuring that a range of diagnostic tests, such as fecal occult blood tests, flexible sigmoidoscopies, and colonoscopies, are covered by health insurance plans. This amendment is an important step towards improving preventive healthcare measures in the state, potentially leading to earlier detection and treatment of colorectal cancer.

Sentiment

The sentiment surrounding HB 361 appears largely positive among legislators and community health advocates, who view it as a necessary measure to enhance healthcare access and affordability. Supporters argue that the bill will reduce barriers to screening and encourage more individuals to participate in preventive health programs. Conversely, there may be some concerns regarding the cost implications for insurance providers, but the overall consensus leans toward the bill's beneficial effects on public health.

Contention

While the bill has garnered substantial support, challenges remain in its implementation, particularly concerning the concerns raised by some insurance companies about the potential increase in coverage costs. However, the overarching goal of HB 361 is to facilitate a preventive healthcare culture that emphasizes the importance of early detection of colorectal cancer, ensuring the state’s commitment to protecting public health is maintained. The debate reflects a broader dialogue about healthcare accessibility and the responsibilities of insurance providers.

Companion Bills

No companion bills found.

Previously Filed As

LA HB1196

Provides relative to coverage of colorectal cancer screening, colonoscopies, and associated preventive services (EN NO IMPACT See Note)

LA HB421

AN ACT relating to colorectal cancer screenings.

LA H1286

Relative to colorectal and breast cancer screenings

LA HB1123

In casualty insurance, further providing for coverage for colorectal cancer screening.

LA AR89

Relative to Colorectal Cancer Awareness Month.

LA HB1969

Relating To Colorectal Cancer.

LA HB556

Relating To Colorectal Cancer.

LA HB556

Relating To Colorectal Cancer.

LA HCR36

Requesting The Auditor To Assess The Social And Financial Effects Of Proposed Mandatory Health Insurance Coverage For Colorectal Cancer Screenings.

LA HB1061

Health insurance; require policies to cover Cologuard colorectal cancer screening tests.

Similar Bills

No similar bills found.